Could a common heart pill help dialysis patients? new trial aims to find out
NCT ID NCT07417215
First seen Feb 21, 2026 · Last updated May 14, 2026 · Updated 13 times
Summary
This study tests whether the drug sacubitril/valsartan can improve heart function in people with a specific type of heart failure (HFpEF) who are also on chronic hemodialysis. About 60 adults will be randomly assigned to receive the drug or standard care. The main goal is to see if the drug reduces heart chamber size and improves heart strain over two months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Clinical Hospital Mostar
Mostar, 88000, Bosnia and Herzegovina
Conditions
Explore the condition pages connected to this study.